Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines for Europe Country Specific Market Access Policies

23 May 2017

Policy

Read More

ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Read more

Essential Medicines for Universal Health Coverage

7 November 2016

Policy

Read More

Medicines for Europe’s Contribution to WHO’s Biological Qualifier (BQ) Developments (PRESENTATION and SPEECH)

18 October 2016

Policy

      18 October 2016 Suzette Kox Senior Director […]

Read more

Understanding the Science of Extrapolation and Defining Interchangeability – Dr. Elena Wolff-Holz, EULAR Symposium London

10 June 2016

Policy

Read More

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report

Read More

EGA-EBG Summary Position Regarding the WHO Biologic Qualifier Proposal (INN Working Doc. 14.342)

21 March 2016

Policy

Read More

Biosimilar Product Labelling

2 February 2016

Policy

Read More

The value of generic medicines

26 November 2015

Policy

Read more about the value of generic medicines PDF version or […]

Read more

EGA-EBG Considerations on WHO’s BQ Proposal – Suzette Kox, WHO INN Open Session with Stakeholders, Geneva, 13 October 2015 (PPT)

13 October 2015

Policy

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]